We then monitored the cell viability of 3 different BCP-ALL cell lines upon the usage of an anti-DCTD drug tetrahydrouridine (NCI Thesaurus Code: C868) at 10 μM showing a strong downregulation in the cell viability (Fig. 7F). This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.